Search results
RevoluGROUP Announces CEO and Director Stepping Down
Digital Journal· 1 day agoPRESS RELEASE Published May 2, 2024 GlobeNewswire VANCOUVER, British Columbia and BARCELONA, Spain., May 02, 2024 (GLOBE NEWSWIRE) -- RevoluGROUP Canada Inc. (TSX-
Salisbury defendant with case related to Jan. 6 attack has hearing date moved to May
Delmarva Now | The Daily Times via Yahoo News· 4 days agoDistrict Court...Columbia. The most recent court document shows that the parties in the case, United...
Billie Jean King Cup Finals: Great Britain to face Germany
BBC News· 4 days agoGreat Britain have been drawn against Germany in the first round of the Billie Jean King Cup Finals...
Glynn Academy v Lassiter Elite Eight
The Brunswick News· 3 days agoClick here to view this item from The Brunswick News.
Global survey shows COVID booster uptake in question
Center for Infectious Disease Research and Policy· 3 days agoWillingness to get a booster dose of vaccine dropped most notably in high-income countries compared to middle-income countries. In the richest...
2 downtown Phoenix cocktail bars named in new 'Michelin-style guide for the bar industry'
AZCentral | The Arizona Republic via Yahoo News· 1 day agoThe symbols are an upside down V with a period over the apex for one pin, two inverted Vs (like two mountains), each with a period on the apex for two pins and...apex for ...
Pandemic fatigue and vaccine hesitancy continue to affect global public health, new 23-country study...
Medical Xpress· 5 days ago"The repercussions of pandemic disruptions in health care services, the effects of the inequitable...
Amendment 4 rebuttal
Citrus Chronicle Online· 3 days agoRegulating abortion is a balance of two interests: (1) the mother's right to control her body, and (2) the life of the fetus. In many countries, abortion is permitted "on
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 22 hours agoAllschwil, Switzerland, May 03, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that
